Is my portfolio
One Report to Answer all your Questions!
Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Large Cap | Pharmaceuticals & Drugs
1175.55
-10.90 (-0.92%) Dr.Reddy's Laboratories informs about press release
Date: 19-12-2022Dr.Reddy's Laboratories has informed that it enclosed Press Release titled 'Dr. Reddy's successfully completes Phase 1 study of DRL_TC, a proposed biosimilar of tocilizumab’.
The above information is a part of company’s filings submitted to BSE.